abstract |
Disclosed is a drug and a therapeutic method for treating late-onset Gaucher disease. Ambroxol, bromhexine, or a derivative thereof having activity as a pharmacological chaperone of a mutant of β-glucocerebrosidase. Therapeutic methods provide a therapeutically effective amount of the composition to a patient in need of treatment. [Selection figure] None |